Under a microscope, melanoma appears as a disorganized proliferation of abnormal pigment-producing cells (melanocytes) that have lost the orderly architecture of normal skin. Where a benign mole shows evenly spaced, uniform clusters of cells sitting neatly at the base of the skin’s ridges, melanoma shows irregularly shaped cells scattered haphazardly through multiple layers of skin, often migrating upward into tissue where melanocytes don’t normally belong.
Overall Architecture: Asymmetry and Disorder
The first thing a pathologist notices when examining a melanoma slide is asymmetry. If you drew a line down the center of the tissue specimen, the two halves wouldn’t mirror each other. The borders of the lesion are poorly defined, with melanocytes trailing off irregularly into surrounding skin rather than stopping at a clean edge. A benign mole, by contrast, has very sharp lateral margins where the cell population ends abruptly.
Melanoma cells also don’t respect the normal rules of skin organization. In healthy skin, melanocytes sit in a single layer at the junction between the outer skin (epidermis) and the deeper tissue (dermis). In melanoma, cells appear at all levels of the epidermis, sometimes clustered in irregular nests of varying sizes, sometimes scattered individually. This chaotic arrangement is one of the strongest visual signals that something has gone wrong.
What the Individual Cells Look Like
Melanoma cells themselves look distinctly abnormal compared to their healthy counterparts. Their nuclei are enlarged, roughly 20% larger on average than those of cells in a dysplastic (atypical but non-cancerous) mole. The nuclear membrane, which in healthy melanocytes appears smooth and round, becomes irregular and wavy. Inside the nucleus, the genetic material (chromatin) takes on a coarse, clumpy appearance and tends to concentrate around the edges, creating a ring-like pattern. Benign melanocyte nuclei, by comparison, have chromatin distributed more evenly throughout.
Pathologists also look for cellular pleomorphism, meaning the cells vary dramatically in size and shape rather than looking uniform. Prominent nucleoli, small dense structures inside the nucleus involved in making proteins, are another hallmark. These features collectively signal that the cells have lost normal growth controls.
Pagetoid Spread: Cells Climbing Upward
One of the most telling microscopic features of melanoma is called pagetoid spread, where melanocytes migrate upward through the epidermis in a scattered, discontinuous pattern. Normally melanocytes stay anchored at the base of the epidermis. When they appear as individual cells or small clusters in the upper layers of skin, it’s a strong indicator of malignancy.
Pagetoid spread is present in about 96% of melanomas. It tends to be diffuse and extensive, often with significant cellular atypia visible in the migrating cells. This pattern can occasionally appear in certain benign conditions like moles on the palms and soles (61% of cases) or Spitz nevi (38%), but in those situations the spread is usually focal and limited, without the atypia seen in melanoma. It’s essentially never found in ordinary acquired moles.
How Different Melanoma Types Appear
Not all melanomas look the same under the microscope. The major subtypes each have distinct growth patterns that pathologists can identify on a slide.
Superficial spreading melanoma, the most common type, is characterized by its horizontal growth phase. Atypical melanocytes spread laterally through the epidermis before invading downward. Under the microscope, you see abundant single melanocytes scattered throughout the epidermis in a haphazard pattern, with runs of individual cells immediately adjacent to large nests sitting next to smaller nests. The lateral spread of abnormal cells in the epidermis often extends well beyond any tumor component in the deeper dermis.
Nodular melanoma skips the horizontal phase entirely and grows aggressively downward from the start. On a slide, the most striking feature is large nests and sheets of atypical melanocytes pushing deep into the dermis. The epidermal component doesn’t extend laterally beyond the dermal component, which correlates with its clinical appearance as a raised bump rather than a spreading patch.
Lentigo maligna melanoma develops from a precursor lesion that has been growing slowly on sun-damaged skin for years or decades. Microscopically, atypical melanocytes line up along the basal layer of the epidermis in a pattern called lentiginous hyperplasia, with eventual invasion into the dermis.
Desmoplastic melanoma is a rare subtype that can fool even experienced pathologists. Instead of the typical appearance of pigmented cancer cells, it produces dense fibrous tissue that resembles scar tissue. The tumor cells are often spindle-shaped and embedded within this fibrous stroma, making them hard to distinguish from the surrounding connective tissue without special staining techniques.
Amelanotic melanoma lacks the melanin pigment that gives most melanomas their dark appearance. Without pigment to flag abnormal cells, these tumors can be particularly challenging to identify and often require additional testing to confirm the diagnosis.
Mitotic Figures: Cells Caught Dividing
Pathologists count the number of cells actively dividing (mitotic figures) within a standardized area of the tumor, reported as mitoses per square millimeter. A cell caught mid-division has a distinctive appearance on a slide: the nucleus breaks apart into visible chromosome clusters being pulled to opposite ends of the cell. In melanoma, these dividing cells can be found in the dermal component of the tumor, and their frequency reflects how aggressively the cancer is growing. A count of zero mitoses per square millimeter is the best scenario; counts can range up to 100 or more in highly aggressive tumors.
Breslow Thickness: Measuring Depth
One of the most important measurements a pathologist makes is Breslow thickness, the distance from the top of the tumor down to the deepest cancer cell. This is measured directly on the microscope slide using a calibrated eyepiece, reported to the nearest tenth of a millimeter. If the skin surface over the tumor is intact, measurement starts from the granular layer at the top of the epidermis. If the surface is ulcerated (broken open), measurement starts from the base of the ulcer. This single number is one of the strongest predictors of outcome and directly determines the tumor’s stage.
Signs of the Immune System Fighting Back
Melanoma slides frequently show evidence of the body’s immune response. Tumor-infiltrating lymphocytes, small round immune cells, can be seen pushing into and around the tumor mass on standard stained slides. Pathologists classify this response as brisk (lymphocytes diffusely infiltrating the entire base of the tumor), non-brisk (patchy or focal infiltration), or absent. A brisk lymphocyte response is associated with lower risk of the cancer spreading and better survival.
In some cases, the immune system partially or completely destroys portions of the tumor, a process called regression. Under the microscope, regression appears as areas where cancer cells have been replaced by scar-like fibrous tissue, often accompanied by immune cells called macrophages that have ingested leftover melanin pigment. Early regression looks like granulation tissue with new blood vessels and immature connective tissue cells. Late regression shows mature scar tissue with flattening of the overlying skin surface and loss of the normal ridge pattern at the skin’s base.
Special Stains That Confirm the Diagnosis
When the diagnosis isn’t clear from the standard tissue stain alone, pathologists use immunohistochemical stains that bind to specific proteins found in melanocytes. These stains highlight melanoma cells in a contrasting color against the background tissue, making even tiny clusters of cancer cells visible. One widely used marker targets a protein involved in the development of melanocytes from their precursor cells and produces crisp nuclear staining that makes individual tumor cells easy to spot. This is particularly useful for finding tiny deposits of melanoma in lymph nodes, where scattered cancer cells might otherwise be lost among thousands of normal immune cells. Other markers highlight the cytoplasm of melanocytes or pigment-related proteins, each with slightly different strengths depending on the clinical question.
How Melanoma Differs From a Benign Mole
The distinction between melanoma and a benign mole under the microscope comes down to a constellation of features rather than any single finding. Benign moles show symmetry, sharp borders, evenly spaced nests of uniform cells confined to the tips of the skin’s ridges, and no cells migrating into the upper epidermis. The nuclei are small, round, and have smoothly distributed chromatin.
Dysplastic (atypical) moles sit in a gray zone. They show some architectural disorder and mild to moderate variation in cell size and shape, but these changes are limited to the junction between the epidermis and dermis. Melanoma pushes beyond these boundaries with atypia extending into the deeper dermis, diffuse pagetoid spread throughout the epidermis, and the constellation of nuclear abnormalities, mitotic activity, and tissue disorganization that collectively define malignancy. In difficult cases, the chromatin distribution pattern inside the nucleus can be the tiebreaker: melanoma nuclei tend to have chromatin concentrated at the periphery, while dysplastic mole nuclei keep their chromatin more evenly spread.